Phase 1 Study of the Safety, Reactogenicity, and Immunogenicity of AMA1-C1/ISA 720: Blood Stage Vaccine for Plasmodium Falciparum
Clinical trial NCT00487916 · COMPLETED
Trial details
- NCT number
- NCT00487916
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-13
- Primary completion
- 2009-02-05
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.